Cargando…
Autologous natural killer cells as a promising immunotherapy for locally advanced colon adenocarcinoma: Three years follow‐up of resectable case
BACKGROUND: Over the last decade, a new modality of immunotherapy has been announced, with the expectation of better long‐term clinical outcomes and disease‐free survival after the definitive surgical treatment of colon cancer. Natural killer (NK) cells as part of cellular therapy in immunotherapy h...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480413/ https://www.ncbi.nlm.nih.gov/pubmed/37439389 http://dx.doi.org/10.1002/cnr2.1866 |